G. Beasley

James X. Sun, K. Delman, D. Tyler, 2020, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

International Multicenter Experience of Isolated Limb Infusion for In-Transit Melanoma Metastases in Octogenarian and Nonagenarian Patients

James X. Sun, K. Delman, D. Tyler, 2020, Annals of Surgical Oncology.

Efficacy of Talimogene Laherparepvec (T-VEC) Therapy in Patients with In-Transit Melanoma Metastasis Decreases with Increasing Lesion Size

J. Stewart, P. Mosca, G. Beasley, 2019, Annals of Surgical Oncology.

Long–Term Oncologic Outcomes After Isolated Limb Infusion for Locoregionally Metastatic Melanoma: An International Multicenter Analysis

James X. Sun, K. Delman, D. Tyler, 2019, Annals of Surgical Oncology.

Prospective multicenter phase II trial of systemic ADH-1 in combination with melphalan via isolated limb infusion in patients with advanced extremity melanoma.

Merrick I Ross, Stephen R Grobmyer, M. Ross, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Src Family Kinase Inhibition as a Novel Strategy to Augment Melphalan-Based Regional Chemotherapy of Advanced Extremity Melanoma

C. Augustine, D. Tyler, R. Turley, 2014, Annals of Surgical Oncology.

Future directions in regional treatment strategies for melanoma and sarcoma

M. Ross, D. Tyler, G. Beasley, 2008, International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group.

In-transit Melanoma Metastases: Incidence, Prognosis, and the Role of Lymphadenectomy

D. Tyler, G. Beasley, 2015, Annals of Surgical Oncology.

Safety and Efficacy of RP1 + Nivolumab in Patients with Non-Melanoma Skin Cancer of the Head and Neck: Results From IGNYTE Phase 1/2 Multi-Cohort Clinical Trial

B. Chmielowski, A. Vanderwalde, J. Sacco, 2022, International Journal of Radiation Oncology*Biology*Physics.

Trends in Racial, Ethnic, and Sex Representation Among Surgical Faculty Members and Medical Students in the US, 2011-2020.

Y. Iwai, R. Sudan, G. Beasley, 2021, JAMA surgery.

Diversity Among Surgical Faculty, Residents, and Oncology Fellows from 2011/2012 to 2019/2020

Y. Iwai, R. Sudan, G. Beasley, 2022, Annals of Surgical Oncology.

Isolated Limb Infusion for In-Transit Malignant Melanoma of the Extremity: A Well-Tolerated but Less Effective Alternative to Hyperthermic Isolated Limb Perfusion

R. Petersen, D. Tyler, H. Seigler, 2008, Annals of Surgical Oncology.

Can binimetinib, encorafenib and masitinib be more efficacious than currently available mutation-based targeted therapies for melanoma treatment?

D. Tyler, A. Salama, G. Beasley, 2017, Expert opinion on pharmacotherapy.

Melanoma lymph node metastases – moving beyond quantity in clinical trial design and contemporary practice

G. Beasley, K. Rhodin, D. Burner, 2022, Frontiers in Oncology.

Active surveillance of patients who have sentinel node positive melanoma: An international, multi‐institution evaluation of adoption and early outcomes after the Multicenter Selective Lymphadenectomy Trial II (MSLT‐2)

James X. Sun, Lesly A. Dossett, V. Sondak, 2021, Cancer.

Adjuvant Radiation Therapy for Clinical Stage III Melanoma in the Modern Therapeutic Era

James X. Sun, V. Sondak, Dennie T. Frederick, 2020, Annals of Surgical Oncology.

Characterization of Sentinel Lymph Node Immune Signatures and Implications for Risk Stratification for Adjuvant Therapy in Melanoma

Sin-Ho Jung, D. Tyler, M. Selim, 2020, Annals of Surgical Oncology.

Updates in adjuvant systemic therapy for melanoma

C. Slingluff, A. Salama, B. Hanks, 2018, Journal of surgical oncology.

Sentinel Lymph Node Biopsy for Recurrent Melanoma: A Multicenter Study

D. Tyler, C. Slingluff, A. Terando, 2017, Annals of Surgical Oncology.

A Multicenter Phase I Dose Escalation Trial to Evaluate Safety and Tolerability of Intra-arterial Temozolomide for Patients with Advanced Extremity Melanoma Using Normothermic Isolated Limb Infusion

M. Ross, C. Augustine, D. Tyler, 2014, Annals of Surgical Oncology.

A multi-institutional experience of isolated limb infusion: defining response and toxicity in the US.

M. Ross, A. Caudle, K. Delman, 2009, Journal of the American College of Surgeons.

Patterns of Recurrence Following Complete Response to Regional Chemotherapy for In-Transit Melanoma

D. Tyler, B. Peterson, G. Broadwater, 2012, Annals of Surgical Oncology.

A Multi-institutional Experience of Repeat Regional Chemotherapy for Recurrent Melanoma of Extremities

D. Tyler, S. Hochwald, S. Grobmyer, 2012, Annals of Surgical Oncology.

Predictive Factors of Regional Toxicity and Serum Creatine Phosphokinase Levels After Isolated Limb Infusion for Melanoma: A Multi-Institutional Analysis

M. Ross, K. Delman, D. Tyler, 2009, Annals of Surgical Oncology.

A Phase I Multi-Institutional Study of Systemic Sorafenib in Conjunction with Regional Melphalan for In-Transit Melanoma of the Extremity

C. Augustine, D. Tyler, M. Selim, 2012, Annals of Surgical Oncology.

A phase 1 study of systemic ADH‐1 in combination with melphalan via isolated limb infusion in patients with locally advanced in‐transit malignant melanoma

M. Ross, R. Norris, C. Augustine, 2009, Cancer.

Burden of Disease Predicts Response to Isolated Limb Infusion with Melphalan and Actinomycin D in Melanoma

D. Tyler, Z. Thompson, J. Zager, 2014, Annals of Surgical Oncology.

Resection of Residual Disease after Isolated Limb Infusion (ILI) Is Equivalent to a Complete Response after ILI-Alone in Advanced Extremity Melanoma

D. Tyler, J. Wong, K. Fisher, 2014, Annals of Surgical Oncology.

Optimizing regional infusion treatment strategies for melanoma of the extremities

C. Augustine, D. Tyler, A. Coleman, 2009, Expert review of anticancer therapy.

Sorafenib, a Multikinase Inhibitor, Enhances the Response of Melanoma to Regional Chemotherapy

Sin-Ho Jung, C. Augustine, J. S. Yoo, 2010, Molecular Cancer Therapeutics.

Computed Tomography-Based Limb Volume Measurements for Isolated Limb Infusion in Melanoma

T. Jaffe, D. Tyler, A. Salama, 2016, Annals of Surgical Oncology.

A multi‐institution experience comparing the clinical and physiologic differences between upper extremity and lower extremity melphalan‐based isolated limb infusion

M. Dewhirst, D. Tyler, J. Wong, 2012, Cancer.

Bevacizumab-Induced Alterations in Vascular Permeability and Drug Delivery: A Novel Approach to Augment Regional Chemotherapy for In-Transit Melanoma

M. Dewhirst, A. Fontanella, G. Hanna, 2012, Clinical Cancer Research.

Standardizing Regional Therapy: Developing a Consensus on Optimal Utilization of Regional Chemotherapy Treatments in Melanoma

D. Tyler, G. Beasley, 2011, Annals of Surgical Oncology.

Optimizing Regional Therapy for Melanoma

D. Tyler, G. Beasley, 2009, Annals of Surgical Oncology.

Predictors of False Negative Sentinel Lymph Node Biopsy in Clinically Localized Merkel Cell Carcinoma

James X. Sun, V. Sondak, C. Slingluff, 2021, Annals of Surgical Oncology.

A phase I study of systemic sorafenib in combination with isolated limb infusion with melphalan (ILI-M) in patients (pts) with locally advanced in-transit melanoma.

C. Augustine, D. Tyler, M. Selim, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A phase I/II study of systemic ADH-1 in combination with isolated limb infusion with melphalan (ILI-M) in patients (pts) with locally advanced in-transit melanoma

M. Ross, C. Augustine, P. Zipfel, 2008 .

Adjuvant Therapy is Effective for Melanoma Patients with a Positive Sentinel Lymph Node Biopsy Who Forego Completion Lymphadenectomy

Taylor P Williams, D. Tyler, G. Beasley, 2020, Annals of Surgical Oncology.

Prognostic or Therapeutic-The Role of Sentinel Lymph Node Biopsy in Contemporary Practice.

D. Tyler, G. Beasley, K. Rhodin, 2022, JAMA surgery.

ASO Author Reflections: Adjuvant Therapy is Effective for Melanoma Patients with Positive Sentinel Lymph Node Biopsy Who Forgo Completion Lymphadenectomy

G. Beasley, N. E. Farrow, 2020, Annals of Surgical Oncology.

A Multicenter Prospective Evaluation of the Clinical Utility of F-18 FDG-PET/CT in Patients With AJCC Stage IIIB or IIIC Extremity Melanoma

A. Abernethy, D. Tyler, G. Broadwater, 2012, Annals of surgery.

Treatment of in-transit melanoma: an opportunity to discover critical knowledge.

D. Tyler, G. Beasley, 2011, Oncology.

Outcomes with adjuvant anti-PD-1 therapy in patients with sentinel lymph node-positive melanoma without completion lymph node dissection

James X. Sun, Lesly A. Dossett, T. Hieken, 2022, Journal for ImmunoTherapy of Cancer.

An Internally Validated Prognostic Risk-Score Model for Disease-Specific Survival in Clinical Stage I and II Merkel Cell Carcinoma

James X. Sun, V. Sondak, C. Slingluff, 2022, Annals of Surgical Oncology.

Simultaneous diaphragm and liver resection: a propensity-matched analysis of postoperative morbidity.

D. Tyler, B. Clary, R. Turley, 2013, Journal of the American College of Surgeons.

Melanoma trials that defined surgical management: Overview of trials that established NCCN margin guidelines

C. Slingluff, G. Beasley, J. Sharib, 2021, Journal of surgical oncology.

Nodal Recurrence as Primary Driver of Early Relapse in Patients with SLN-Positive Melanoma: What Does It Mean for Providers and Patients?

G. Beasley, K. Rhodin, Nellie Farrow, 2021, Annals of Surgical Oncology.

Potential Utility of Synthetic D-Lactate Polymers in Skin Cancer

Jennifer Y. Zhang, A. Salama, G. Beasley, 2021, JID innovations.

Mind the gap: Gendered publication trends in oncology

A. Salama, M. Palta, G. Beasley, 2020, Cancer.

What's new in neoadjuvant therapy for breast cancer?

J. Olson, G. Beasley, 2010, Advances in surgery.

Percutaneous hepatic perfusion (PHP) with melphalan for patients with ocular melanoma liver metastases: Preliminary results of FOCUS (PHP-OCM-301/301A) phase III trial.

A. Gesierich, A. Ejaz, R. Dummer, 2021 .

A SREBF2-dependent gene program drives an immunotolerant dendritic cell population during cancer progression

Xuepeng Wang, Yue Xue, N. DeVito, 2023, bioRxiv.

Intratumor childhood vaccine-specific CD4+ T-cell recall coordinates antitumor CD8+ T cells and eosinophils

D. Bigner, A. Desjardins, S. Nair, 2022, Journal for ImmunoTherapy of Cancer.

International Center-Level Variation in Utilization of Completion Lymph Node Dissection and Adjuvant Systemic Therapy for Sentinel Lymph Node-Positive Melanoma at Major Referral Centers

James X. Sun, Lesly A. Dossett, V. Sondak, 2022, Annals of surgery.

Melanomas of Unknown Primary May Have a Distinct Molecular Classification to Explain Differences in Patient Outcomes

G. Beasley, 2020, Annals of Surgical Oncology.

Outcomes of Single Node Excision Compared with Lymph Node Dissection for Patients with Clinical Stage III N1b Cutaneous Melanoma

P. Gimotty, C. Slingluff, G. Karakousis, 2023, Annals of Surgical Oncology.

National Trends in Management of Pathologic Stage III Melanoma

D. Tyler, G. Beasley, K. Rhodin, 2023, Annals of Surgical Oncology.

657 Characterization and therapeutic targeting of a tumor-associated tolerogenic DC subpopulation driven by SREBP2 and the mevalonate metabolic pathway

N. DeVito, M. Plebanek, B. Hanks, 2021, Journal for ImmunoTherapy of Cancer.

Multicenter Experience with Neoadjuvant Therapy in Melanoma Highlights Heterogeneity in Contemporary Practice

D. Tyler, C. Slingluff, Elizabeth M. Gaughan, 2022, Annals of surgery.

Great Debate: Limb Infusion for Melanoma: A Thing of the Past?

J. Zager, G. Beasley, K. Rhodin, 2023, Annals of surgical oncology.

A prospective multicenter phase II trial of systemic ADH-1 in combination with melphalan via isolated limb infusion (M-ILI) in patients with advanced extremity melanoma.

M. Ross, D. Tyler, S. Hochwald, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Acral Melanomas of the Sole May Have Worse Prognosis Compared with Other Sites of Acral Melanoma

G. Beasley, 2020, Annals of Surgical Oncology.

Functional reprogramming of peripheral blood monocytes by soluble mediators in patients with pancreatic cancer and intraductal papillary mucinous neoplasms

B. Sullenger, S. Nair, D. Boczkowski, 2023, Frontiers in immunology.

Isolated Limb Infusion for Melanoma

P. Kam, J. Zager, P. Lindnér, 2018, Cutaneous Melanoma.

Diagnostic dilemma of gastric pneumatosis with portal vein gas

D. Moris, T. Pappas, G. Beasley, 2019 .

Timing of Adjuvant Immunotherapy in Stage III Melanoma, Does it Matter?

S. H. A. Chen, M. Iyer, D. Tyler, 2023, Annals of surgical oncology.

Survey Study of Clerkship Curriculum on Learner's Choice to Pursue Surgery: Positive Impact of Extracurricular Opportunities.

Y. Iwai, R. Sudan, C. Quinsey, 2023, Journal of surgical education.

Initial efficacy and safety of RP1 + nivolumab in patients with anti–PD-1–failed melanoma from the ongoing phase 1/2 IGNYTE study.

D. Schadendorf, J. Hou, M. Middleton, 2023, Journal of Clinical Oncology.

Intratumor childhood vaccine-specific CD4+ T-cell recall coordinates antitumor CD8+ T cells and eosinophils

D. Bigner, A. Desjardins, S. Nair, 2023, Journal for ImmunoTherapy of Cancer.

Bevacizumab-Induced Alterations in Vascular Permeability and Drug Delivery: A Novel Approach to Augment Regional Chemotherapy for In-Transit Melanoma

M. Dewhirst, A. Fontanella, G. Hanna, 2012, Clinical Cancer Research.

Type of Organ Transplanted Impacts the Risk and Presentation of Cutaneous Squamous Cell Carcinoma in Transplant Recipients.

P. Mosca, G. Beasley, A. Barbas, 2020, Experimental and Clinical Transplantation.

A phase 1 study of systemic ADH‐1 in combination with melphalan via isolated limb infusion in patients with locally advanced in‐transit malignant melanoma

M. Ross, R. Norris, C. Augustine, 2009, Cancer.

LASSO and Elastic Net Tend to Over-Select Features

G. Beasley, Lu Liu, Junheng Gao, 2023, Mathematics.

ASO Author Reflections: Gene Expression-Profiling and Implications for Adjuvant Therapy in Melanoma

G. Beasley, N. E. Farrow, 2021, Annals of Surgical Oncology.